Latest Releases
U.S. Senator Tina Smith Joins Elizabeth Warren, Banking Committee Democrats in Pressing SEC Chair to Require Disclosure of Corporate Lobbying Expenditures
Washington, D.C. — Today, U.S. Senators Tina Smith (D – Minn.), Sherrod Brown (D-Ohio.), Jon Tester (D-Mont.) and John Fetterman (D-Pa.) signed onto a letter led by Senator Elizabeth Warren (D – Mass.) urging Gary Gensler, Chair of the U.S. Securities and Exchange Commission (SEC), to create new rules requiring public companies to disclose their spending on lobbying efforts. Public companies are not currently required to report information on the details of their lobbying to the SEC even as corporate lobbying expenditures reach record highs. “In 2022, total federal lobbying expenditures reached $4.1 billion – the highest since 2010. Amazon and Meta spent almost $20 million each to influence decision-making in Congress and across government agencies, while the U.S. Chamber of Commerce – which counts companies like JPMorgan Chase, Alphabet, and Chevron among its members – spent $79.4 million,” wrote the senators. “While these figures are staggering, they provide little insight into the interests that companies spend millions each year to advance. This lack of transparency erodes the ability of everyday investors to make informed decisions about where to invest their money – and where their money goes once they have invested.” Specifically, the senators are requesting that such rules require disclosure of lobbying strategy, the total amount of direct or indirect contributions to registered state and federal lobbyists and any material risks related to or arising from lobbying strategies and expenditures. The senators requested the SEC provide them with details on their plans to develop and issue such rules no later than
U.S. Senators Tina Smith, Tom Cotton Reintroduce Bipartisan Legislation to Boost U.S. Pharmaceutical Manufacturing
WASHINGTON, D.C. — Today, Senators Tina Smith (D-MN) and Tom Cotton (R-AR) reintroduced bipartisan legislation to reduce dependence on foreign pharmaceutical manufacturing and boost production in the U.S. The pandemic exposed our nation’s dependence on other countries for essential prescription drugs. Seventy-seven percent of key pharmaceutical ingredients come from overseas, including from China, threatening the security of the supply chain and leading to shortages of essential prescription drugs. The American Made Pharmaceuticals Act would reduce our dependence on foreign countries for pharmaceuticals by boosting production here at home. The legislation would create federal incentives to onshore manufacturing of essential medicine, while taking steps to shore up links in the supply chain. “We know that depending on foreign countries for key resources – whether it’s oil or medicine – leaves us vulnerable to global supply chain shocks and shortages,” said Sen. Smith. “This bipartisan legislation would reduce our dependence on foreign pharmaceutical manufacturing and help boost production here at home. I look forward to getting this bill across the finish line so we can relieve prescription drug shortages and build more resilient supply chains.” “The Chinese Communist Party threatened to cut off America’s access to vital drugs during the pandemic,” said Sen. Cotton. “It’s time to bolster onshore manufacturing of pharmaceuticals to ensure Americans never have to rely on China for lifesaving medicine.” “Amneal applauds Senators Smith and Cotton on their targeted approach to increase pharmaceutical manufacturing here in the United States,” said Chirag Patel, President & Co-CEO of Amneal Pharmaceuticals. “Ensuring that
U.S. Sen. Tina Smith, U.S. Rep. Dean Phillips Introduce Legislation to Support Family Mental Health Services
WASHINGTON, D.C. [05/02/19]—U.S. Senator Tina Smith (D-Minn.) and U.S. Representative Dean Phillips (D-Minn.) have teamed up to introduce companion bills that would update landmark legislation to prioritize making sure the child welfare system supports and connects families to needed mental health services. The Child Abuse Prevention and Treatment Act (CAPTA) was enacted 45 years ago and governs important child protection programs and services to prevent, assess, and identify child abuse and neglect—and it is the only federal program exclusively dedicated to these aims. Sen. Smith and Rep. Phillips’s bill—the Supporting Family Mental Health in CAPTA Act—would update CAPTA to improve
U.S. Sens. Tina Smith and Bill Cassidy Lead Bipartisan Push to Lower Wasteful Health Care Spending
WASHINGTON, D.C. [05/01/19]—Today, U.S. Senators Tina Smith (D-Minn.) and Bill Cassidy, M.D. (R-La.) introduced bipartisan legislation to help develop innovative ways to reduce unnecessary administrative costs in health care spending. Estimates suggest that while administrative costs could account for over one quarter of total health care spending in the United States, much of it is not directly related to delivering patient care. Sens. Smith and Cassidy’s bill—the Reducing Administrative Costs and Burdens in Health Care Act, which was first introduced last Congress—would direct the Secretary of Health and Human Services to take steps toward reducing unnecessary administrative costs across the
U.S. Senator Tina Smith Highlights Bill to Boost Mental Health Services for Students While Visiting Minnesota Elementary School
WASHINGTON, D.C. [04/25/19]—Today, U.S Senator Tina Smith (D-Minn.) announced she’s reintroduced her legislation to make sure students in schools across the nation are able to access the mental health services they need, where they are, while visiting Franklin Elementary School in Rochester. While hearing from Rochester area educators and mental health professionals, Sen. Smith discussed her Mental Health Services for Students Act, which would provide funding for comprehensive mental health services in schools. Young people experience mental health conditions about as often as adults—about 1 in 5 struggle with severe mental health problems—but they often have a hard time getting
U.S. Sen. Tina Smith Presses Nation’s Top Agriculture, Drug Enforcement, and Customs Officials to Clear Bureaucratic Hurdles for Minnesota Farmers Growing Industrial Hemp
WASHINGTON, D.C. [04/19/19]—After taking a leading role in making sure Minnesota priorities were included in the 2018 Farm Bill, this week U.S. Senator Tina Smith (D-Minn.)—a member of the Senate Agriculture Committee—is once again standing up for Minnesota farmers by pressing top federal agriculture, drug enforcement, and customs officials to clear the bureaucratic hurdles that are preventing Minnesota farmers from obtaining hemp seed. Sen. Smith said last year’s Farm Bill established hemp as an agriculture commodity, and authorized the production, consumption, and sale of hemp in Minnesota and across the country. However, she said, a lack of coordination between federal
English